Guide to US Reimbursement for Drugs, Medical Devices, and Diagnostics

by Boston Healthcare

Securing FDA approval or clearance is not a guarantee of payer coverage or payment for your novel drug or device. D&MD's Guide to US Reimbursement for Drugs, Medical Devices, and Diagnostics is a comprehensive review of how medical technologies secure payment from private and public payers. The Guide examines coverage, coding, and payment issues from private payer (HMO, PPO) and public payer (Medicare, Medicaid) perspectives. The Guide is indispensable for life science technology executives who are responsible for reimbursement strategy, securing reimbursement, or assessing the value of a new technology with reimbursement in mind. D&MD's Guide to US Reimbursement for Drugs, Medical Devices, and Diagnostics will provide insight to a wide audience of product managers, reimbursement planners, business development executives, and CEOs.

Key Benefits

> A comprehensive guide that provides key reimbursement concepts for pharmaceutical, medical devices and the diagnostic industries, and complements FDA regulatory knowledge to assist in market planning at all levels of the product development cycle

> Updated CMS reimbursement news on guidelines and timelines in an 'actionable' format to aid in the marketability of products

> Details on CMS submissions for coding and coverage with charted explanations on differentiating the need for new coding and its integration into your marketing plan

> A strategic tool for successful 'in-house' reimbursement with links to payment systems at the public level and turnkey solution for monitoring policy

March 2006, Pages 140, FOormat PDF
Table of Contants
Brochure
Price: $895.00 / GBP447.50